The global Giant Cell Arteritis Therapeutics Market is experiencing significant growth, driven by an aging population, increased awareness, and advancements in treatment options. Valued at approximately USD 1.1 billion in 2023, the market is projected to reach USD 1.9 billion by 2031, expanding at a CAGR of 6.2% during the forecast period.  Top 5 Companies with the Largest...